This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Karuna Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: David G Evans - Innovator in Pharmaceutical Compounds
Introduction
David G Evans is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address medical conditions.
Latest Patents
David holds a patent for "Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditions." This invention provides substituted tetrahydropyrrolo-pyridinone compounds, pharmaceutical compositions, and their application in treating muscarinic acetylcholine receptor mediated disorders. His innovative work has the potential to impact various therapeutic areas.
Career Highlights
David is currently associated with Karuna Therapeutics, Inc., where he continues to advance his research and development efforts. His expertise in pharmaceutical compounds has positioned him as a valuable asset in the industry.
Collaborations
Some of his notable coworkers include Kevin Matthew Gardinier and James Edmund Audia. Their collaborative efforts contribute to the innovative environment at Karuna Therapeutics, Inc.
Conclusion
David G Evans is a distinguished inventor whose work in pharmaceutical compounds showcases his commitment to addressing medical challenges. His contributions are paving the way for advancements in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile